---
title: amyloidosis
---

# amyloidosis

- [[rheumatology]]

> [[Systemic diseases with secondary glomerular involvement]]

- [[overview of amyloidosis|overview]] 󰒖

- lightchian disease
- Deposition of misfolded proteins as insoluble fibrils (β-pleated sheets) in normal tissues
- 最常見的四種系統性分別是 AL、AA、Ab2M、和遺傳與老年相關的（ATTR）

---

![🖼️ Figure: _](https://i.imgur.com/m7pkAYA.png)

---

- [[clinical manifestations of amyloidosis]]
- [[diagnostic studies of amyloidosis]] 󰒗
- [[primary amyloidosis]] (AL)
- [[treatment of amyloidosis]]

- Clearance of amyloid by Ab under study
  - (NEJM 2015;373:1106; Br J Haematol 2020;189:228)
- Cardiac:
  - diuretics;
  - avoid CCB;
  - ↑ dig toxicity risk (? amyloid binding);
  - anticoag all AF
- Heart, kidney, and liver transplant
  - may be considered in those w/ advanced disease
- Median survival:
  - 5y AL (~6 m if CM);
  - 11y AA;
  - 4y wt ATTR & 2.5y ATTR V122I CM w/o Rx
